PARANASAL SINUS AND NASAL CAVITY MALIGNANT NEOPLASM

PARANASAL SINUS AND NASAL CAVITY MALIGNANT NEOPLASM was reported 7 times

PARANASAL SINUS AND NASAL CAVITY MALIGNANT NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Isocitrate Dehydrogenase 1 Inhibitor [EPC] 1 0.0005
1 Osmotic Diuretic [EPC] 1 0.0002
2 BCL-2 Inhibitor [EPC] 1 0.0000
3 Nitrate Vasodilator [EPC] 1 0.0000
4 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
5 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
6 Azole Antifungal [EPC] 1 0.0000
7 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000